Simulations Plus, Inc. (NASDAQ:SLP) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a report released on Thursday.
Separately, Zacks Investment Research upgraded Simulations Plus from a “hold” rating to a “buy” rating and set a $17.00 price objective for the company in a report on Tuesday, July 25th.
Shares of Simulations Plus (NASDAQ:SLP) opened at 16.65 on Thursday. The firm’s 50-day moving average price is $14.97 and its 200-day moving average price is $13.11. Simulations Plus has a 52-week low of $8.10 and a 52-week high of $17.40. The stock has a market cap of $287.13 million, a P/E ratio of 52.86 and a beta of -0.70.
Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Friday, July 14th. The technology company reported $0.13 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.11 by $0.02. Simulations Plus had a return on equity of 23.21% and a net margin of 24.86%. The business had revenue of $6.75 million during the quarter, compared to analyst estimates of $6.48 million. On average, equities research analysts forecast that Simulations Plus will post $0.32 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2017/10/05/simulations-plus-inc-slp-raised-to-buy-at-bidaskclub.html.
In related news, major shareholder Walter S. Woltosz sold 18,500 shares of the stock in a transaction on Wednesday, September 27th. The stock was sold at an average price of $15.45, for a total transaction of $285,825.00. Following the completion of the sale, the insider now directly owns 5,647,916 shares in the company, valued at $87,260,302.20. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 36.93% of the stock is currently owned by company insiders.
A number of institutional investors have recently bought and sold shares of the business. Rice Hall James & Associates LLC increased its position in Simulations Plus by 1.0% during the second quarter. Rice Hall James & Associates LLC now owns 83,819 shares of the technology company’s stock worth $1,035,000 after buying an additional 869 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in Simulations Plus by 13.8% during the second quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock worth $110,000 after buying an additional 1,085 shares during the last quarter. Cadence Capital Management LLC increased its position in Simulations Plus by 5.8% during the second quarter. Cadence Capital Management LLC now owns 110,668 shares of the technology company’s stock worth $1,367,000 after buying an additional 6,044 shares during the last quarter. Menta Capital LLC increased its position in Simulations Plus by 33.9% during the first quarter. Menta Capital LLC now owns 40,102 shares of the technology company’s stock worth $471,000 after buying an additional 10,157 shares during the last quarter. Finally, OxFORD Asset Management LLP acquired a new position in Simulations Plus during the second quarter worth $126,000. 32.01% of the stock is currently owned by hedge funds and other institutional investors.
Simulations Plus Company Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.